RecruitingNot ApplicableNCT06026943

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Advanced Pancreatic Cancer


Sponsor

Alpha Tau Medical LTD.

Enrollment

15 participants

Start Date

Dec 4, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a device called DaRT (Diffusing Alpha-emitters Radiation Therapy), which delivers targeted radiation from inside the tumor using radioactive seeds implanted directly into the pancreatic cancer. This is for patients with locally advanced pancreatic cancer that cannot be surgically removed or whose cancer persisted after chemotherapy. **You may be eligible if...** - You are 18 or older with locally advanced pancreatic cancer confirmed by biopsy - You have already received at least one chemotherapy regimen, or you are medically unable to continue chemotherapy, and surgery is not an option or you refuse surgery - Your tumor is 5 cm or smaller - Your blood counts and organ function meet the minimum requirements **You may NOT be eligible if...** - You received chemotherapy or immunotherapy in the past 4 weeks - You have previously had radiation to your pancreas - You are fit for and willing to have exploratory surgery - You have serious heart disease or uncontrolled infections - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDaRT seeds insertion

An intratumoral insertion of radioactive sources \[Ra-224 containing stainless-steel 316LVM tubes- (Alpha DaRT seeds)\]. The seeds release by recoil into the tumor short-lived alpha-emitting atoms


Locations(1)

Chirurgia Generale e del Pancreas, Istituto del Pancreas

Verona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06026943


Related Trials